Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Advanced Malignancies 2Urothelial Cancer 1Thyroid Neoplasms 1Solid Tumors, KRAS Mutation 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Prostatic Neoplasms 1Prostate Cancer Metastatic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Opioid-Related Disorders 1Lung Neoplasms 1Liposarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Leiomyosarcoma 1KRAS p.G12C Mutant Advanced Solid Tumors 1Hematologic Neoplasms 1Healthy Adult Participants 1Glioma 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Cancer Pain 1

Interventions

Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumors, KRAS Mutation × Midazolam × 1 year × Clear all
NCT04973163 2026-02-17

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Boehringer Ingelheim

Phase 1 Active not recruiting
30 enrolled
Other solid neoplasm

Solid Tumors, KRAS Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡